Quarterly Price Reviews for Indication-Added Drugs Likely to Get Underway in FY2017, Annual Scheme in FY2018: Officials

The Ministry of Health, Labor and Welfare (MHLW) aims to roll out a rule in FY2017 to review NHI reimbursement prices four times each year for drugs that saw market expansions due to additional indications, MHLW officials told reporters on...read more